BIO-key International Statistics
Share Statistics
BIO-key International has 5.82M
shares outstanding. The number of shares has increased by 72.36%
in one year.
| Shares Outstanding | 5.82M |
| Shares Change (YoY) | 72.36% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 4.16% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 6,807 |
| FTD / Avg. Volume | 2.45% |
Short Selling Information
The latest short interest is 105.23K, so 1.81% of the outstanding
shares have been sold short.
| Short Interest | 105.23K |
| Short % of Shares Out | 1.81% |
| Short % of Float | 2.09% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.82 and the forward
PE ratio is -2.13.
BIO-key International's PEG ratio is
0.01.
| PE Ratio | -0.82 |
| Forward PE | -2.13 |
| PS Ratio | 0.51 |
| Forward PS | 0.5 |
| PB Ratio | 0.93 |
| P/FCF Ratio | -1.2 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for BIO-key International.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.41,
with a Debt / Equity ratio of 0.47.
| Current Ratio | 0.41 |
| Quick Ratio | 0.33 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | -0.5 |
| Debt / FCF | -0.61 |
| Interest Coverage | -13.38 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $169,013.93 |
| Profits Per Employee | $-104,894.93 |
| Employee Count | 41 |
| Asset Turnover | 0.8 |
| Inventory Turnover | 3.41 |
Taxes
| Income Tax | -23K |
| Effective Tax Rate | 0.53% |
Stock Price Statistics
The stock price has increased by -58.95% in the
last 52 weeks. The beta is 0.24, so BIO-key International's
price volatility has been higher than the market average.
| Beta | 0.24 |
| 52-Week Price Change | -58.95% |
| 50-Day Moving Average | 0.82 |
| 200-Day Moving Average | 1.09 |
| Relative Strength Index (RSI) | 45.99 |
| Average Volume (20 Days) | 278,092 |
Income Statement
In the last 12 months, BIO-key International had revenue of 6.93M
and earned -4.3M
in profits. Earnings per share was -0.03.
| Revenue | 6.93M |
| Gross Profit | 5.64M |
| Operating Income | -4.01M |
| Net Income | -4.3M |
| EBITDA | -3.55M |
| EBIT | -4.15M |
| Earnings Per Share (EPS) | -0.03 |
Full Income StatementBalance Sheet
The company has 437.6K in cash and 1.78M in
debt, giving a net cash position of -1.34M.
| Cash & Cash Equivalents | 437.6K |
| Total Debt | 1.78M |
| Net Cash | -1.34M |
| Retained Earnings | -129.31M |
| Total Assets | 11.18M |
| Working Capital | 1.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -2.91M
and capital expenditures -13.05K, giving a free cash flow of -2.93M.
| Operating Cash Flow | -2.91M |
| Capital Expenditures | -13.05K |
| Free Cash Flow | -2.93M |
| FCF Per Share | -1.42 |
Full Cash Flow StatementMargins
Gross margin is 81.39%, with operating and profit margins of -57.88% and -62.06%.
| Gross Margin | 81.39% |
| Operating Margin | -57.88% |
| Pretax Margin | -62.39% |
| Profit Margin | -62.06% |
| EBITDA Margin | -51.18% |
| EBIT Margin | -57.88% |
| FCF Margin | -42.24% |
